Hims & Hers Health in discussions with Novo Nordisk to sell Wegovy

7 hours ago 1
Two packages of 5 dosing pens each of a fictitious Semiglutin drug used for weight loss (antidiabetic medication or anti-obesity medication) on a blue transparent background. Fictitious package design

aprott/iStock via Getty Images

Hims & Hers Health (HIMS) said that it is in "active discussions" with Novo Nordisk (NVO) to sell the Danish drugmakers GLP-1 weight loss therapy Wegovy as well as a pill version of the medicine in development.

Details of a

Recommended For You

More Trending News

Read Entire Article